BUILDING CLINICAL EVIDENCE

Introduction to quality improvement projects (QIP)

What happens after submission

We aim to make the process as open and straightforward as possible. Here’s a summary of how we assess your proposal and when you can expect to hear from us.

  1. We confirm receipt of your proposal and ask for more information if we need it.
  2. Once we’ve received the information we need, we review your proposal, looking at: medical relevance and merits, alignment with Mölnlycke clinical and health economic evidence strategy, regulatory status of the product(s) involved in the project, adherence to ethical standards, your qualifications, the overall scientific merit of the project and whether your budget request is within fair market value. We may ask additional questions before we can make a decision.
  3. After about a month, you receive a written response with a rationale for our decision. We may decide to give you final approval, offer conditional approval or reject your proposal.
  4. Once approval is in place, we prepare a Support Agreement describing the responsibilities of everyone involved. 

If you have any questions, please feel free to contact our Global Medical Affairs team via email at medical.affairs@molnlycke.com